Pixantrone (BBR 2778)

DRUG2 trials

Sponsors

CTI BioPharma

Conditions

Lymphoma, FollicularLymphoma, Low-GradeLymphoma, Mixed-Cell, FollicularLymphoma, Small Cleaved-Cell, FollicularLymphoma, Small Lymphocytic

Phase 1

Dose Ranging Trial for Pixantrone in the FND-R Variant Regimen in Indolent Non-Hodgkin's Lymphoma

CompletedNCT00060684

CTI BioPharmaLymphoma, Low-Grade, Lymphoma, Mixed-Cell, Follicular, Lymphoma, Small Cleaved-Cell, Follicular +1

Start: 2001-12-31End: 2007-05-31Target: 30Updated: 2015-01-19

Phase 3

Comparative Trial for Pixantrone in Combination With Rituximab in Indolent Non-Hodgkin's Lymphoma

TerminatedNCT00060671

CTI BioPharmaLymphoma, Follicular, Lymphoma, Low-Grade, Lymphoma, Mixed-Cell, Follicular +1

Start: 2005-01-31End: 2006-01-31Target: 800Updated: 2015-01-19